Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

Also called NCT03044184

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Kwong Wah Hospital (from the registry)
Registry
  • NCT NCT03044184
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03044184. Randomized; double masking; primary purpose treatment. Start 2017-04-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
Acronym
TRANSACT
Condition
Stroke Hemorrhagic
Condition
Intracerebral Haemorrhage
Intervention (Drug)
Tranexamic Acid
Lead sponsor
Kwong Wah Hospital (class: other)

Record details

Record id
cardio:ct-nct03044184
Content hash
9b2424d586689f3908765b4b764d704e50471df13386f1d2a7d804605fe5529a